News

A recent study published in the Annals of the Rheumatic Diseases shows that ankylosing spondylitis is linked to an increased risk for venous thromboembolism and deep vein thrombosis.

Smoking in axial spondyloarthritis doesn't appear to impact treatment with TNF inhibitors despite the status of disease severity, a study shows.

Lack of trust in physicians, lack of information about biologics, medicine substitutions and the search for alternative therapies are among the reasons patients turn to the internet, a new study shows.

Historically, treatments for children with systemic juvenile idiopathic arthritis (sJIA) have been difficult and ineffective, leading to poor outcomes. But, findings from a new study point to a method that could lead to more positive results.

The therapy has been approved for use along with the One-Press injector—a device designed to fit comfortably in the patient’s hand and hide the needle through administration.

The 2018 American College of Rheumatology and the National Psoriasis Foundation released updated treatment guidelines for psoriatic arthritis (PsA). Test your knowledge of the current therapeutic recommendations for PsA in this quiz.

Higher lupus disease activity may be associated with bacteria from periodontal disease, which may be an important modifiable mediator of SLE disease activity.

The first liquid formulation of the common gout therapy is anticipated to improve instances of dosing adjustment for patients.

Patients who start out being diagnosed with seronegative arthritis probably won’t end up with seropositive rheumatoid arthritis (RA), researchers find.

Biological therapies prescribed for rheumatic diseases may also reduce their long-term risks of cardiovascular diseases (CVD), new research shows.

Patients can play a critical role in disseminating high quality healthcare, and rheumatology has been a trailblazer for giving them a voice in how they receive treatment, physicians write.

The JAK1 inhibitor will be considered as a marketed once-daily therapy for moderate to severe RA in the second half of this year.

A well-established treatment for psoriasis, psoriatic arthritis, and Crohn’s disease failed to work in axial spondyloarthritis patients, a study shows. But the study's failure may tell us more than not.

Total hip replacements are one of the most common and effective surgeries for women and men with osteoarthritis. The surgery can work miracles in patients, but the technology behind the surgery is not indestructible. At what point does failure set in?

A new study in JAMA Dermatology raises an interesting question for physicians who treat psoriasis patients. Does methotrexate work best in patients with plaque psoriasis alone or patients who have both psoriasis and arthritis?

In this quiz, we revisit recent advances made in systemic lupus erythematosus (SLE).

The benefits of exercise to combat the effects of musculoskeletal conditions have been well-documented. Take this quiz to test your knowledge of sports and exercise medicine in rheumatology.

Researchers writing in PLOS One report that patients with ankylosing spondylitis have a significant higher prevalence of dementia and Alzheimer’s dementia than the general population.

The January issue of Arthritis and Rheumatology includes updated treatment guidelines for adults with active psoriatic arthritis. In this article, we take a comprehensive look at the guidelines.

Half of patients with axial spondyloarthritis have both the axial and peripheral forms of the disease, which may explain why these patients have higher disease activity, researchers write in RMD Open.

Two studies of baricitinib monotherapy for adults with moderate to severe atopic dermatitis met primary efficacy endpoints.

An assay designed to track TNF counts in recently-treated RA patients found that early reduction of the protein could indicate future problems for the patient.

The immunosuppressive drug was more effective and resulted in fewer adverse events in patients with psoriasis but without psoriatic arthritis.

Online care and in-person care are equally effective at improving psoriasis symptoms, shows a study published in JAMA Network Open.

New joint guidelines by the American College of Rheumatology and National Psoriasis Foundation recommend psoriatic arthritis patients receive a treat-to-target approach, first-line use of tumor necrosis factor inhibitors biologics, and smoking cessation.

ABP 798, a biosimilar candidate for rituximab, met pharmacokinetic, efficacy, and safety endpoints in a trial among participants with rheumatoid arthritis.

Madelaine A. Feldman, MD, touches on new developments in rheumatology including JAK inhibitor research, genetics and epigenetics, and personalized medicine.

Madelaine A. Feldman, MD, FACR, shares about the current standard treatment rheumatoid arthritis and the hurdles to providing optimal treatment.

What are the most overlooked, difficult-to-treat symptoms within menopause?